Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
To assess equivalence in the rates of functional graft survival at 12 months after
transplantation in patients receiving continuous therapy with cyclosporine (CsA, Sandimmune,
Neoral) and sirolimus versus induction with CsA and sirolimus followed by CsA elimination and
concentration-controlled sirolimus.